About Us

About Us

Meaningful, innovative and evidence-based analysis to
help inform key decision making.

Our goal is to be the business intelligence partner of choice for companies in the healthcare arena looking for meaningful, innovative and evidence-based analysis to inform their key decision making. As a trusted and reliable partner, GBI Research helps clients to better understand their business environment, compete successfully within it, and to achieve growth.

At GBI Research, we leverage extensive proprietary databases and employ novel data interrogation methodologies to generate new and meaningful analyses and insights.

Our content and coverage are informed by close collaboration with a global network of domain-specific external partners; this allows us to deliver novel, thought-provoking and idea-generating insights that clients would normally struggle to access.

Our in-house team of researchers and analysts – typically with MBAs, PhDs and MScs, as well as considerable healthcare industry experience is located across the UK, US and Asia Pacific. The team provides expert and insightful commentary to support evidence-based analyses of established and emerging markets.

More than 2,000 clients benefit from the GBI Research product set. Reports are available to purchase as individual research reports or via our online subscription platform, request a demo today to see how it works.

Analyst Views

29 Jul 16
Respiratory Disorders Set to Benefit from Influx of Novel T....
In this Analyst View, Yasser Mushtaq, Senior Analyst for GBI Research, discusses the resp.....
Read post
29 Jul 16
Ophthalmology: New Molecular Targets to Reshape the Clinica....
In this Expert Insight, Qaisrah Khalid, Associate Analyst for GBI Research, discusses the.....
Read post

White Papers

13 Jul 16
Introducing CBR Pharma Insights....
The latest CBR Pharma Insights white paper, Accelerating your Healthcare Insights, discus....
Read post
27 Oct 15
The Obesity Landscape: Obstacles to Current and Future Weig....
This white paper begins by examining the impact of the global obesity epidemic by conside....
Read post

Press Releases

24 Aug 16
Diabetes and obesity therapeutics market will more than dou....
The global market for diabetes mellitus and obesity is set to rise from $70.8 billion in .....
Read post
22 Aug 16
Chronic pain treatment pipeline could yield innovative alte....
Although opioids continue to dominate the chronic pain market, adverse events associated .....
Read post